All News

The NCPDP’s Executive Vice President of Innovation & Standards joins Drug Topics to discuss how AI has been making itself known within the pharmacy profession.

Rick Sage, Executive Vice President of Innovation & Standards at NCPDP, discusses his role and how his team is using innovation to support the pharmacy profession.

Larry King, PharmD, joins Drug Topics at NCPDP 2025 to discuss pharmacy interoperability, changes in its regulations, and how technology will fall into place within the data infrastructure.

In part 3 of our interview with Vin Gupta, MD, he discusses pharmacists’ role in remote patient care amid a growing technological infrastructure.

In the second part of our interview with Miranda Rochol, she discusses challenges regarding digital prescription solutions and the financial burdens these solutions are designed for pharmacists to overcome.

In her expertise as a leader with the American Pharmacists Association, Brigid Groves, PharmD, MS, provides insights into her work with geographical information systems and maps.

Vin Gupta, MD, discusses trends and perspectives in patient data privacy as well as what a “smart pharmacy” may look like in the near future.

Cami Agena, Esq, and Candida Ruesga, Esq, discuss pharmacy benefit manager reform by providing insights from their experience as legal partners in complex PBM matters.

Larry King, PharmD, discusses how pharmacy interoperability is working to create collaborative care and get pharmacists “in the game” as he says.

Vin Gupta, MD, former Chief Medical Officer at Amazon Pharmacy and renowned US medical analyst, discusses pharmacists’ ability to reach communities and address social determinants of health.

Miranda Rochol, Senior Vice President of Provider Solutions at Prescryptive Health, discusses digital prescription solutions and how they are turning patients into consumers.

Brigid Groves, PharmD, MS, Vice President of Professional Affairs at APhA, discusses how the pharmacist’s role in immunization has adapted in recent history.

A conversation with Douglas Hoey, RPh, MBA, CEO of NCPA, on the chain pharmacy’s announcement of a second Chapter 11 bankruptcy.

Stanley V. Campbell, Jr., CEO of EagleForce Associates, Inc., and Yi Deng, PhD, Senior Vice President of Engineering at EagleForce, explore real-world examples of AI giving time back to pharmacists.

Stanley V. Campbell, Jr., CEO of EagleForce Associates, Inc., and Yi Deng, PhD, Senior Vice President of Engineering at EagleForce, discuss how AI is being used to benefit patients.

Antonio Ciaccia, President of 3 Axis Advisors, CEO of 46brooklyn Research, and pharmacy benefits expert, discusses the commonly circulated misconceptions about PBMs.

A conversation with Sarah Thomas and David Skomo of HealthDyne at Asembia’s AXS25 Summit.

A conversation with Shawn Griffin, MD, FAAFP, President and CEO of URAC, at Asembia’s AXS25 Summit.

A conversation with Harry Travis, BSPharm, President of the Travis Health Group, at Asembia’s AXS25 Summit.

A conversation with Casey Koch, PharmD, MBA, BCACP, clinical pharmacy coordinator at SelectHealth, at Asembia’s AXS25 Summit.

A conversation with Becky Davis, principal at Charles River Associates, at Asembia’s AXS25 Summit.

Expert on drug pricing and pharmacy benefits, Antonio Ciaccia joined Drug Topics to discuss how PBMs came to hold so much control of the pharmaceutical supply chain.

Luke Turnock, PhD, discusses the role of pharmacists and medication counselors in addressing the challenges of increased direct-to-consumer drug advertising on social media.

Antonio Ciaccia, President of 3 Axis Advisors, CEO of 46brooklyn Research, and pharmacy benefits expert, discusses litigious, market-based, and legislative reform for pharmacy benefit managers.

Expert in drug markets, Luke Turnock, PhD, joined Drug Topics to assess where he thinks recent trends in drug advertising will lead patients in the near-to-long-term future.

Mark Garofoli, PharmD, MBA, BCGP, CPE, CTTS, discusses trends in over-the-counter pain medications amid the ongoing opioid emergency in the US.

At AAP 2025, Greg Mitchell, owner of United Drug Superstore, discussed how retail pharmacies can leverage vaccine services to build long-term patient relationships.

At AAP 2025, Mark Garofoli, PharmD, MBA, BCGP, CPE, CTTS, discussed how Disney’s approach to customer service can be applied in a community pharmacy setting.